Context Therapeutics Inc.
CNTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $62,366 | $58,254 | $61,337 |
| - Cash | $76,938 | $83,517 | $89,352 | $94,430 |
| + Debt | $21 | $167 | $194 | $219 |
| Enterprise Value | – | -$20,983 | -$30,904 | -$32,874 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$4 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$9,689 | -$9,754 | -$5,525 | -$4,307 |
| % Margin | – | – | – | – |
| Net Income | -$9,693 | -$8,828 | -$4,577 | -$3,343 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.1 | -0.093 | -0.05 | -0.057 |
| % Growth | -7.9% | -85.4% | 12.6% | – |
| Operating Cash Flow | -$6,579 | -$5,835 | -$5,028 | -$4,907 |
| Capital Expenditures | $0 | $0 | -$34 | $0 |
| Free Cash Flow | -$6,579 | -$5,835 | -$5,062 | -$4,907 |